AzTrials
AzTrials

Mild Cognitive ImpairmentM&MresearchNCT02113345

The Relationship Between Metamemory and Memory in Old Age

A study testing Metamemory Cognitive Intervention in people with Mild Cognitive Impairment, run by The University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this research is to explore the relationship of metamemory and memory of elders and to evaluate the effectiveness of a metamemory cognitive intervention on elders with mild cognitive impairment and low memory self-efficacy. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Mild Cognitive Impairment
What is being tested?
Metamemory Cognitive Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteHong Kong
Study dates
Apr 2014to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Study 1:
  • Participants are Chinese elderly of age 65 or above and they speak Cantonese as their primary language. They are to be recruited from a convenience sample of clients who are without cognitive problems and are attending service in the Elderly Health Centres (EHC) of the Elderly Health Service of the Department of Health, Hong Kong Special Administrative Region Government (HKSARG).
  • Study 2:
  • In addition to the inclusion criteria of Study 1, EHC members with confirmed dementia, suspected dementia, and suspected MCI will also be invited to participate in Study 2. However, confirmed demented clients and suspected demented clients must show their capacity to appraise by passing Quality of Life Appraisal Inventory (CapQOL) (Wong, J.G.W.S. et al., 2005) before they are accepted to the Study. All clients are recruited upon consent.
  • Study 3:
  • Suspected MCI participants of Study 2 with below average memory self-efficacy assessed to have MCI (according to operational definition) will be invited and recruited to Study 3 upon consent. In the present research, MCI is defined operationally according to prior local studies and determined with reference to the educational level-adjusted cutoff scores of Chinese Mini Mental Status Examination (CMMSE) and Abbreviated version of Memory Inventory for the Chinese combined (Lam, L. C.W. \& et al., 2005; Lam, L.C.W. \& et al., 2008).

Who cannot join

  • The presence of currently active medical conditions potentially affecting cognition e.g. vitamin B12 deficiency, hypothyroidism, chronic alcoholism, delirium, and active psychiatric disorders e.g. schizophrenia
  • Other conditions that might affect cognitive competency e.g. aphasia, severe visual or hearing impairment.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Research Site

    Hong Kong

Other trials in Hong Kong

About this study

The purpose of this research is to explore the relationship of metamemory and memory of elders and to evaluate the effectiveness of a metamemory cognitive intervention on elders with mild cognitive impairment and low memory self-efficacy.

Read the detailed description

There are 3 studies in the present research. Study 1 is a reliability and validity study of the Chinese Metamemory Scales. Study 2 is a cross-sectional study to explore the relationship between metamemory and memory of elders encountered in Hong Kong primary health care setting.Study 3 is an Effectiveness Study of Metamemory Cognitive Intervention on elders with mild cognitive impairment and low memory self-efficacy.

This research has the following aims and hypotheses:

Research Aims:

  1. To evaluate the reliability and validity of the Chinese Metamemory Scales
  2. To explore the relationship between metamemory and memory of elders
  3. To evaluate the effectiveness of a metamemory cognitive intervention on Mild Cognitive Impairment (MCI) elders who have low memory self-efficacy

Research Hypotheses:

Study 1: The Chinese Metamemory Scales will show acceptable psychometric properties.

Study 2: There is a positive correlation between metamemory (subjective memory) and memory (objective memory) and this relationship is mediated by stereotyped beliefs about memory ageing.

Study 3: Comparing to Control Group, the Intervention Group will yield the following expected results:

  1. There is an improvement in objective memory measures post-training.
  2. There is an improvement in subjective memory measures post-training.
  3. There is an improvement in mood measures post-training.
Being tested
Metamemory Cognitive Intervention
Keywords
metamemory, memory, mild cognitive impairment
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Metamemory Cognitive InterventionBehavioural

    Metamemory Cognitive Intervention

Study groups in NCT02113345
Study groupRoleWhat they receive
lifestyle counselingExperimentalMetamemory Cognitive Intervention
Receives: Behavioral: Metamemory Cognitive Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Objective Memory Measures

    change from baseline in Hong Kong List Learning Test, 2nd Edition (HKLLT, Chan, A.S., 2006) for verbal episodic memory

    Measured: Baseline, post-intervention at week 16

  2. Objective Memory Measures

    Change from baseline in Figure Recognition of Memory Assessment Scale (MAS, Williams, 1991) for visual episodic memory

    Measured: Baseline, post-intervention at week 16

  3. Objective Memory Measures

    Change from baseline in Category Verbal Fluency Test (CVFT, categories to be chosen with reference to local studies by published by Chiu, H.F.K. et al., 1997 and Mok et al., 2004) for semantic memory

    Measured: Baseline, post-intervention at week 16

  4. Objective Memory Measures

    Change from baseline in Digit Span and Visual Spatial Span from (MAS, Williams, 1991) for verbal and visual memory working memory

    Measured: Baseline, post-intervention at week 16

  5. Objective Memory Measures

    Change from baseline in Event-based and Time-based Tasks for prospective memory (tasks to be developed with reference to the recommendations of Wilson, B.A. \& et al., 2008)

    Measured: Baseline, post-intervention at week 16

Secondary outcomes (4)
  1. Subjective Memory Measures

    Change from baseline in the Chinese version of Memory Self-efficacy Scale (MSE, Frequency of Forgetting-10 Scale, Zelinski and Gilewski, 2004)

    Measured: Baseline, post-intervention at week 16

  2. Subjective Memory Measures

    Change from baseline in Chinese versions of the Abbreviated version of Memory Inventory for the Chinese (AMIC, Lam, Linda, C. W. \& et al., 2005)

    Measured: Baseline, post-intervention at week 16

  3. Subjective Memory Measures

    Change from baseline in Chinese versions of the Anxiety about Memory (AM, a subscale of the Memory Functioning Questionnaire, Gilewski, Zelinski \& Schaie, 1990, for Study 1 only)

    Measured: Baseline, post-intervention at week 16

  4. Subjective Memory Measures

    Change from baseline in Chinese versions of the Stereotypes about Memory Aging (SMA, Fort \& Gana, 2009)

    Measured: Baseline, post-intervention at week 16

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionMar 2016 (estimated)
  4. Study completionMar 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02113345
Sponsor's protocol ID
082010Deb
Acronym
M&Mresearch
Status last verified
Apr 2014
First submitted
12 Mar 2014
Last updated
14 Apr 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Metamemory Cognitive Intervention in people with Mild Cognitive Impairment, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Objective Memory Measures (time frame: Baseline, post-intervention at week 16). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in